• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » BioWorld Stock Report For Public Biotechnology Companies

BioWorld Stock Report For Public Biotechnology Companies

Jan. 10, 2005

Article reprints

To read more on related topics, click on one of the words below.

BioWorld MedTech

      • Related Articles

        BioWorld Stock Report For Public Biotechnology Companies

        BioWorld Stock Report For Public Biotechnology Companies

        BioWorld Stock Report For Public Biotechnology Companies

      Popular Stories

      • Today's news in brief

        BioWorld
        BioWorld briefs for June 18, 2025.

      • Today's news in brief

        BioWorld MedTech
        BioWorld MedTech briefs for June 18, 2025.

      • News in brief

        BioWorld Asia
        BioWorld Asia briefs for June 17, 2025
      • Stock chart, upward arrow

        An early stage 85% remissions rate in AML drives Aptevo’s stock surge

        BioWorld
        An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...

      • Jyong’s $20M US IPO to help refile NDA of urological botanic drug

        BioWorld
        Jyong Biotech Ltd. raised $20 million from its Nasdaq debut June 17 to advance a pipeline of botanical drugs targeting male urinary disorders. The New Taipei...
      • BioWorld
        • Today's news
        • Analysis and data insight
        • Clinical
        • Data Snapshots
        • Deals and M&A
        • Financings
        • Newco news
        • Opinion
        • Regulatory
        • Science
      • BioWorld MedTech
        • Today's news
        • Clinical
        • Data Snapshots
        • Deals and M&A
        • Financings
        • Newco news
        • Opinion
        • Regulatory
        • Science
      • BioWorld Asia
        • Today's news
        • Analysis and data insight
        • Australia
        • China
        • Clinical
        • Deals and M&A
        • Financings
        • Newco news
        • Regulatory
        • Science
      • BioWorld Science
        • Today's news
        • Biomarkers
        • Cancer
        • Conferences
        • Endocrine/Metabolic
        • Immune
        • Infection
        • Neurology/Psychiatric
        • Patents
      • More
        • About
        • Advertise with BioWorld
        • Archives
        • Article reprints and permissions
        • Contact us
        • Cookie policy
        • Copyright notice
        • Data methodology
        • Infographics: Dynamic digital data analysis
        • Index insights
        • Podcasts
        • Privacy policy
        • Share your news with BioWorld
        • Staff
        • Terms of use
        • Topic alerts
      Follow Us

      Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

      BioWorld. Link to homepage.

      Clarivate
      • BioWorld
      • BioWorld MedTech
      • BioWorld Asia
      • BioWorld Science
      • Data Snapshots
        • BioWorld
        • BioWorld MedTech
        • Infographics: Dynamic digital data analysis
        • Index insights
      • Special reports
        • Infographics: Dynamic digital data analysis
        • Trump administration impacts
        • Biopharma M&A scorecard
        • BioWorld 2024 review
        • BioWorld MedTech 2024 review
        • BioWorld Science 2024 review
        • Women's health
        • China's GLP-1 landscape
        • PFA re-energizes afib market
        • China CAR T
        • Alzheimer's disease
        • Israel
        • Rise of obesity
        • Radiopharmaceuticals
        • Biosimilars
        • Aging
        • IVDs on the rise
        • Coronavirus
        • Artificial intelligence

      BioWorld. Link to homepage.

      • Sign In
      • Sign Out
      • My Account
      Subscribe